Liquid pharmaceutical formulations containing 3,7-diazabicyclo[3,3,1] nonanes for treating anti-arrhythmic events

Liquid pharmaceutical formulations containing 3,7-diazabicyclo[3,3,1] nonanes for treating anti-arrhythmic events

The present invention relates to the use of 3,7-diazabicyclo[3,3,1]nonane compounds, preferably of 9,9-alkylene-3,7-diazabicyclo[3,3,1]nonane compounds, and most preferably to the use of tedisamil, and the physiologically acceptable acid addition salts and/or solvates thereof, in the form of a liqui...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: MATTHIAS STRAUB, WERNER CAUTREELS, CLAUS RUDOLF STEINBORN, JOHANNES WILHELMUS CATHARINE MARIA JANSEN, MICHIEL HENRICUS DE VRIES
Format: Patent
Sprache:eng
Schlagworte:
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page
container_issue
container_start_page
container_title
container_volume
creator MATTHIAS STRAUB
WERNER CAUTREELS
CLAUS RUDOLF STEINBORN
JOHANNES WILHELMUS CATHARINE MARIA JANSEN
MICHIEL HENRICUS DE VRIES
description The present invention relates to the use of 3,7-diazabicyclo[3,3,1]nonane compounds, preferably of 9,9-alkylene-3,7-diazabicyclo[3,3,1]nonane compounds, and most preferably to the use of tedisamil, and the physiologically acceptable acid addition salts and/or solvates thereof, in the form of a liquid pharmaceutical preparation for the treatment and/or inhibition of anti-arrhythmic events in human patients, preferably in conversion of recent onset of atrial fibrillation or flutter to normal sinus rhythm in humans. Furthermore, the invention concerns related methods of treatment and pharmaceutical products.
format Patent
fullrecord <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_AU2003296580BB8</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>AU2003296580BB8</sourcerecordid><originalsourceid>FETCH-epo_espacenet_AU2003296580BB83</originalsourceid><addsrcrecordid>eNqNjjEKwkAQANNYiPqHKywTiDnUWBpRLCy1EpH1sjELyV5ytxHi643gA6ymmYEZB-2J2o5y1ZTgajDYCRmoVGFd3VUgZNkrY1mAmPipdLiOcoI3PMj0prJXHepwcVNsGRj9t1PicAgHGVgoAufKXsqajMIXsvhpMCqg8jj7cRLMD_vz7hhhY-_om2GCUe7bSxLHOtmslmmcZan-U_sAJvVE9A</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Liquid pharmaceutical formulations containing 3,7-diazabicyclo[3,3,1] nonanes for treating anti-arrhythmic events</title><source>esp@cenet</source><creator>MATTHIAS STRAUB ; WERNER CAUTREELS ; CLAUS RUDOLF STEINBORN ; JOHANNES WILHELMUS CATHARINE MARIA JANSEN ; MICHIEL HENRICUS DE VRIES</creator><creatorcontrib>MATTHIAS STRAUB ; WERNER CAUTREELS ; CLAUS RUDOLF STEINBORN ; JOHANNES WILHELMUS CATHARINE MARIA JANSEN ; MICHIEL HENRICUS DE VRIES</creatorcontrib><description>The present invention relates to the use of 3,7-diazabicyclo[3,3,1]nonane compounds, preferably of 9,9-alkylene-3,7-diazabicyclo[3,3,1]nonane compounds, and most preferably to the use of tedisamil, and the physiologically acceptable acid addition salts and/or solvates thereof, in the form of a liquid pharmaceutical preparation for the treatment and/or inhibition of anti-arrhythmic events in human patients, preferably in conversion of recent onset of atrial fibrillation or flutter to normal sinus rhythm in humans. Furthermore, the invention concerns related methods of treatment and pharmaceutical products.</description><language>eng</language><subject>HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2010</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20100318&amp;DB=EPODOC&amp;CC=AU&amp;NR=2003296580B8$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25543,76293</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&amp;date=20100318&amp;DB=EPODOC&amp;CC=AU&amp;NR=2003296580B8$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>MATTHIAS STRAUB</creatorcontrib><creatorcontrib>WERNER CAUTREELS</creatorcontrib><creatorcontrib>CLAUS RUDOLF STEINBORN</creatorcontrib><creatorcontrib>JOHANNES WILHELMUS CATHARINE MARIA JANSEN</creatorcontrib><creatorcontrib>MICHIEL HENRICUS DE VRIES</creatorcontrib><title>Liquid pharmaceutical formulations containing 3,7-diazabicyclo[3,3,1] nonanes for treating anti-arrhythmic events</title><description>The present invention relates to the use of 3,7-diazabicyclo[3,3,1]nonane compounds, preferably of 9,9-alkylene-3,7-diazabicyclo[3,3,1]nonane compounds, and most preferably to the use of tedisamil, and the physiologically acceptable acid addition salts and/or solvates thereof, in the form of a liquid pharmaceutical preparation for the treatment and/or inhibition of anti-arrhythmic events in human patients, preferably in conversion of recent onset of atrial fibrillation or flutter to normal sinus rhythm in humans. Furthermore, the invention concerns related methods of treatment and pharmaceutical products.</description><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2010</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjjEKwkAQANNYiPqHKywTiDnUWBpRLCy1EpH1sjELyV5ytxHi643gA6ymmYEZB-2J2o5y1ZTgajDYCRmoVGFd3VUgZNkrY1mAmPipdLiOcoI3PMj0prJXHepwcVNsGRj9t1PicAgHGVgoAufKXsqajMIXsvhpMCqg8jj7cRLMD_vz7hhhY-_om2GCUe7bSxLHOtmslmmcZan-U_sAJvVE9A</recordid><startdate>20100318</startdate><enddate>20100318</enddate><creator>MATTHIAS STRAUB</creator><creator>WERNER CAUTREELS</creator><creator>CLAUS RUDOLF STEINBORN</creator><creator>JOHANNES WILHELMUS CATHARINE MARIA JANSEN</creator><creator>MICHIEL HENRICUS DE VRIES</creator><scope>EVB</scope></search><sort><creationdate>20100318</creationdate><title>Liquid pharmaceutical formulations containing 3,7-diazabicyclo[3,3,1] nonanes for treating anti-arrhythmic events</title><author>MATTHIAS STRAUB ; WERNER CAUTREELS ; CLAUS RUDOLF STEINBORN ; JOHANNES WILHELMUS CATHARINE MARIA JANSEN ; MICHIEL HENRICUS DE VRIES</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_AU2003296580BB83</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2010</creationdate><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>MATTHIAS STRAUB</creatorcontrib><creatorcontrib>WERNER CAUTREELS</creatorcontrib><creatorcontrib>CLAUS RUDOLF STEINBORN</creatorcontrib><creatorcontrib>JOHANNES WILHELMUS CATHARINE MARIA JANSEN</creatorcontrib><creatorcontrib>MICHIEL HENRICUS DE VRIES</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>MATTHIAS STRAUB</au><au>WERNER CAUTREELS</au><au>CLAUS RUDOLF STEINBORN</au><au>JOHANNES WILHELMUS CATHARINE MARIA JANSEN</au><au>MICHIEL HENRICUS DE VRIES</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Liquid pharmaceutical formulations containing 3,7-diazabicyclo[3,3,1] nonanes for treating anti-arrhythmic events</title><date>2010-03-18</date><risdate>2010</risdate><abstract>The present invention relates to the use of 3,7-diazabicyclo[3,3,1]nonane compounds, preferably of 9,9-alkylene-3,7-diazabicyclo[3,3,1]nonane compounds, and most preferably to the use of tedisamil, and the physiologically acceptable acid addition salts and/or solvates thereof, in the form of a liquid pharmaceutical preparation for the treatment and/or inhibition of anti-arrhythmic events in human patients, preferably in conversion of recent onset of atrial fibrillation or flutter to normal sinus rhythm in humans. Furthermore, the invention concerns related methods of treatment and pharmaceutical products.</abstract><oa>free_for_read</oa></addata></record>
fulltext fulltext_linktorsrc
identifier
ispartof
issn
language eng
recordid cdi_epo_espacenet_AU2003296580BB8
source esp@cenet
subjects HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title Liquid pharmaceutical formulations containing 3,7-diazabicyclo[3,3,1] nonanes for treating anti-arrhythmic events
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T10%3A59%3A23IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=MATTHIAS%20STRAUB&rft.date=2010-03-18&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EAU2003296580BB8%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true